Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1999
11/10/1999EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/10/1999EP0863873B1 Indole carbamates as leukotriene antagonists
11/10/1999EP0766691B1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
11/10/1999EP0724588B1 Drug binding protein
11/10/1999EP0610487B1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234800A Naphthyridine derivatives
11/10/1999CN1234799A 1,4-disubstituted piperazines
11/10/1999CN1234797A N-substituted azaheterocyclic compound
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234237A Chinese medicine preparation for radically curing dyamenorrhea and its preparation method and using method
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046274C Isoxazoline compounds as antinflammatory agents
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981767 Method of producing dry thioctic acid
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981547 Homochroman derivatives and related compounds useful as anti-inflammatory agents
11/09/1999US5981544 For treatment of diseases involving an alteration in the venous function and/or inflammatory edema
11/09/1999US5981543 Method of treating androgenic alopecia with 5α-reductase inhibitors
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981517 Androstene derivatives
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981479 Administering to the aids patient a nonimmunosuppressive, cyclophilin-bining cyclosporin which binds to human genetic engineered cyclophilin and has an activity in the mixed lymphocyte reaction of not more than 10% that of ciclosporin
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981256 Recombinant stratum corneum chymotryptic enzyme (SCCE)
11/09/1999US5981232 Mammalian hydrolase; diagnosis, prevention, and treatment of inflammatory diseases and cancer; anticarcinogenic agents; antiinflammatory agents
11/09/1999US5980954 Modifying the extracted blood aliquot from patient by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation, forming an autoimmune vaccine to treat rheumatoid arthritis
11/09/1999US5980953 Anti-inflammatory factor, method of isolation, and use
11/09/1999US5980892 Increasing cytotoxicity by exposing t lymphocytes to a monoclonal antibody, reacting with an epitope of the variable region of a t cell antigen receptor; treating rheumatoid arthritis
11/09/1999US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/09/1999CA2106452C Amidinophenol derivatives
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055830A2 Process for synthesizing cox-2 inhibitors
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055696A1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055669A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate
11/04/1999WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999WO1999055322A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999045909A3 Use of nitrone compounds for the inhibition of angiogenesis
11/04/1999WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
11/04/1999CA2327363A1 Process for the preparation of methyl(2s)-2-¬(3r)-3-(n-¬tert-butyloxycarbonyl|-amino)-2-oxopyrrolidin-1-yl|propionate
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999EP0952974A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/03/1999EP0952853A2 Conjugate comprising an active agent, a polypeptide and a polyether
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1233962A Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same
11/02/1999USRE36375 Treatment of Alzheimer's disease using azacyclic compounds
11/02/1999US5977384 Benzothiazolone derivatives
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977161 Kappa-opiate agonists effective in the treatment of postoperative ileus
11/02/1999US5977151 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
11/02/1999US5977135 Bicyclic heterocycles
11/02/1999US5977122 Antiinflammatory, antiallergens, tumor necorsis factor inhibitor
11/02/1999US5977119 Trisubstituted thioxanthines
11/02/1999US5977117 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
11/02/1999US5977108 Leukemia
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977096 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976566 Non-steroidal antiinflammtory drug formulations for topical application to the skin
11/02/1999US5976558 Silicone-containing derivatives of salicylic acid which have desquamating properties
11/02/1999US5976556 Combination of acid protease enzymes and acidic buffers and uses thereof
11/02/1999US5976547 Extract of arnica montana in combination with menthol crystal, camphor, oil of mint, eucalyptus oil, guaifenesin, lidocaine blended in either a pluronic lecithin organogel or a petrolatum base.
11/02/1999US5976540 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
11/02/1999US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999US5976504 Topical aerosol formulation for cooling of mammalian tissues
11/02/1999CA2160689C New method of treatment
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
10/1999
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999WO1999054310A2 New substituted amides, their production and their use
10/28/1999WO1999054298A1 Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/28/1999WO1999054293A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/28/1999WO1999053935A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/1999WO1999053934A1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
10/28/1999WO1999053932A1 Streptococcus preparation
10/28/1999WO1999043654A3 Inhibitors of phospholipase enzymes
10/28/1999WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999WO1999024460B1 Dipeptide nitriles
10/28/1999CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
1 ... 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 ... 1272